Correlation Between Neurobo Pharmaceuticals and BWV
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and BWV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and BWV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and BWV, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and BWV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of BWV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and BWV.
Diversification Opportunities for Neurobo Pharmaceuticals and BWV
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurobo and BWV is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and BWV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BWV and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with BWV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BWV has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and BWV go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and BWV
If you would invest 112.00 in BWV on September 15, 2024 and sell it today you would earn a total of 0.00 from holding BWV or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.81% |
Values | Daily Returns |
Neurobo Pharmaceuticals vs. BWV
Performance |
Timeline |
Neurobo Pharmaceuticals |
BWV |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neurobo Pharmaceuticals and BWV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurobo Pharmaceuticals and BWV
The main advantage of trading using opposite Neurobo Pharmaceuticals and BWV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, BWV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BWV will offset losses from the drop in BWV's long position.Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
BWV vs. Virax Biolabs Group | BWV vs. Revelation Biosciences | BWV vs. Kiora Pharmaceuticals | BWV vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |